Target intelligence / Profile preview

Endoplasmic reticulum-Golgi intermediate compartment protein 1 (ERGIC1)

Target
ERGIC1
Molecular classification
Other (cycling membrane protein, cargo receptor)
01

Overview

Endoplasmic reticulum-Golgi intermediate compartment protein 1 (ERGIC1) is a cycling membrane protein localized at the ER-Golgi intermediate compartment, playing a critical role in the regulation of protein trafficking between the endoplasmic reticulum and Golgi apparatus[1][2][3][4][5]. It acts as a modulator in cycling protein complexes, stabilizing proteins such as hErv46, thus ensuring efficient cargo sorting and transport[1][2][4]. Dysregulation or mutation of ERGIC1 impairs developmental protein trafficking and is implicated in diseases such as congenital arthrogryposis multiplex congenita, certain cancers (including prostate and gastric), and potentially neurodegenerative conditions[1][3]. There is, to date, no established evidence that ERGIC1 is a therapeutic target for direct drug intervention, nor are there specific drugs, mechanisms of action, or biomarkers established for this protein[1][3][4].

Other names
ERGIC-32ERGIC32KIAA1181NET24AMCNCDA14ER-Golgi intermediate compartment 32 kDa proteinHT034
02

Biological functions

Protein trafficking between endoplasmic reticulum and GolgiRegulation and stabilization of cycling protein complexesModulation of partner proteins such as hErv46 to ensure efficient cargo transport
03

Disease associations

Developmental disorders (e.g., arthrogryposis multiplex congenita)Cancer (regulation of proliferation and apoptosis in prostate and gastric cancer)Neurodegenerative disease (variants associated with neurodegenerative syndromes)Other (broad defects in cellular homeostasis)

Beyond the preview

Go deeper on Endoplasmic reticulum-Golgi intermediate compartment protein 1 (ERGIC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endoplasmic reticulum-Golgi intermediate compartment protein 1 (ERGIC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call